Skip to main content
Feedback to SSRN
Feedback
(required)
Email
(required)
Submit
Edward Q. Chang
University of Texas MD Anderson Cancer Center - Institute for Applied Cancer Science
Houston, TX
United States
Learn more about SSRN Profiles
SCHOLARLY PAPERS
1
DOWNLOADS
41
TOTAL CITATIONS
1
Feedback
Scholarly Papers (1)
Sort by:
Paper Title, A-Z
Paper Title, Z-A
Author Name, A-Z
Author Name, Z-A
Date Posted, Ascending
Date Posted, Descending
Downloads, Ascending
Downloads, Descending
Citations, Ascending
Citations, Descending
Actions:
Email selected abstracts
View:
Selected
Original List
All Versions
Hide All Versions
All Abstracts
Hide All Abstracts
(Rank)
1.
Enhancer Reprogramming Confers Dependence on Glycolysis and IGF Signaling in KMT2D Mutant Melanoma
Number of pages: 72
Posted: 18 Mar 2020
Mayinuer Maitituoheti
,
Emily Z. Keung
,
Ming Tang
,
Liang Yan
,
Hunain Alam
,
Guangchun Han
,
Ayush T. Raman
,
Christopher Terranova
,
Sharmistha Sarkar
,
Elias Orouji
,
Samir B. Amin
,
Sneha Sharma
,
Maura Williams
,
Neha S. Samant
,
Mayura Dhamdhere
,
Norman Zheng
,
tara shah
,
Amiksha Shah
,
Jacob B. Axelrad
,
Nazanin E. Anvar
,
Yu-Hsi Lin
,
Shan Jiang
, Edward Q. Chang,
Wei-Lien Wang
,
Davis R. Ingram
,
Alexander Lazar
,
Min Gyu Lee
,
Florian Muller
,
Linghua Wang
,
Haoqiang Ying
and
Kunal Rai
University of Texas MD Anderson Cancer Center - Department of Genomic Medicine, University of Texas MD Anderson Cancer Center - Department of Surgical Oncology, University of Texas MD Anderson Cancer Center - Department of Genomic Medicine, University of Texas MD Anderson Cancer Center - Department of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center - Department of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center - Department of Genomic Medicine, University of Texas MD Anderson Cancer Center - Department of Genomic Medicine, University of Texas MD Anderson Cancer Center - Department of Genomic Medicine, University of Texas MD Anderson Cancer Center - Department of Genomic Medicine, University of Texas MD Anderson Cancer Center - Department of Genomic Medicine, Jackson Laboratory for Genomic Medicine, University of Texas MD Anderson Cancer Center - Department of Genomic Medicine, University of Texas MD Anderson Cancer Center - Department of Genomic Medicine, University of Texas MD Anderson Cancer Center - Department of Genomic Medicine, University of Texas MD Anderson Cancer Center - Department of Genomic Medicine, University of Texas MD Anderson Cancer Center - Department of Genomic Medicine, University of Texas MD Anderson Cancer Center - Department of Genomic Medicine, University of Texas MD Anderson Cancer Center - Department of Genomic Medicine, University of Texas MD Anderson Cancer Center - Department of Genomic Medicine, University of Texas MD Anderson Cancer Center - Department of Genomic Medicine, University of Texas MD Anderson Cancer Center, University of Texas MD Anderson Cancer Center - Department of Genomic Medicine, University of Texas MD Anderson Cancer Center - Institute for Applied Cancer Science, University of Texas MD Anderson Cancer Center - Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center - Department of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center - Department of Translational Molecular Pathology, University of Texas at Houston - Department of Molecular and Cellular Oncology, University of Texas MD Anderson Cancer Center, University of Texas at Houston - Department of Genomic Medicine, University of Texas MD Anderson Cancer Center - Department of Molecular and Cellular Oncology and University of Texas MD Anderson Cancer Center - Department of Genomic Medicine
Downloads
41
(1,170,409)
Citation
1
View PDF
Download
Abstract:
Melanoma, KMT2D, Enhancer, Glycolysis, Chromatin, Epigenetics
Feedback